Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet‐activating factor receptor

Although platelet‐activating factor (PAF) has been shown to exert pleiotropic effects on isolated cells or tissues, controversy still exists as to whether it plays significant pathophysiological roles in vivo. To answer this question, we established transgenic mice overexpressing a guinea‐pig PAF receptor (PAFR). The transgenic mice showed a bronchial hyperreactivity to methacholine and an increased mortality when exposed to bacterial endotoxin. An aberrant melanogenesis and proliferative abnormalities in the skin were also observed in the transgenic mice, some of which spontaneously bore melanocytic tumors in the dermis after aging. Thus, PAFR transgenic mice proved to be a useful model for studying the basic pathophysiology of bronchial asthma and endotoxin‐induced death, and screening of therapeutics for these disorders. Furthermore, our findings provide new insights regarding the role of PAF in the morphogenesis of dermal tissues as well as the mitogenic activity of PAF and PAFR in vivo.

[1]  T. Ahmed,et al.  Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin. , 1998, American journal of respiratory and critical care medicine.

[2]  G. Zimmerman,et al.  Platelet-activating Factor Acetylhydrolases* , 1997, The Journal of Biological Chemistry.

[3]  M. Nyman,et al.  Modeling and control of an electric arc furnace using a feedforward artificial neural network , 1996 .

[4]  G. Zimmerman,et al.  Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. , 1996, The Journal of clinical investigation.

[5]  Y. Fukuchi,et al.  Effects of lung volume on airway resistance during induced constriction in papain-treated rabbits. , 1996, Journal of applied physiology.

[6]  K. Kume,et al.  A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. , 1996, The Biochemical journal.

[7]  S. Masushige,et al.  Tissue-specific response of the human platelet-activating factor receptor gene to retinoic acid and thyroid hormone by alternative promoter usage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Takao Shimizu,et al.  Platelet-activating factor receptor: gene expression and signal transduction. , 1995, Biochimica et biophysica acta.

[9]  E. Gelfand,et al.  Identification of functional platelet-activating factor receptors on human keratinocytes. , 1995, The Journal of investigative dermatology.

[10]  H. Narahara,et al.  Platelet-activating factor-acetylhydrolase activity in follicular fluid of patients undergoing in vitro fertilization and embryo transfer. , 1995, Fertility and sterility.

[11]  G. Imokawa,et al.  Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. , 1995, The Journal of investigative dermatology.

[12]  T. Jacks,et al.  A subset of p53-deficient embryos exhibit exencephaly , 1995, Nature Genetics.

[13]  R. Frenkel,et al.  Platelet-activating factor. Role in fetal lung development and relationship to normal and premature labor. , 1995, Clinics in perinatology.

[14]  M. Katsuki,et al.  Increased Tyrosine-Phosphorylation of 55-kDa Proteins in -Actin/ Tec Transgenic Mice , 1995 .

[15]  J. Miyazaki,et al.  Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Kato,et al.  Positive and negative regulations of human platelet-activating factor receptor transcript 2 (tissue-type) by estrogen and TGF-beta 1. , 1994, Biochemical and biophysical research communications.

[17]  S. Kato,et al.  Platelet-Activating Factor (PAF) Positively Auto-Regulates the Expression of Human PAF Receptor Transcript 1 (Leukocyte-Type) Through NF-κB , 1994 .

[18]  I. Adcock,et al.  Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. , 1994, American journal of respiratory cell and molecular biology.

[19]  R. Lefkowitz,et al.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.

[20]  H. Bito,et al.  Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. , 1994, European journal of biochemistry.

[21]  E. Nishida,et al.  Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[22]  Kunio Kato,et al.  Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation , 1994, Nature.

[23]  Z. Honda,et al.  Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin. , 1993, Biochemical and biophysical research communications.

[24]  K. Yamamura,et al.  Transgenic mouse lines with ectopic expression of alpha-1,3-galactosyltransferase: production and characteristics. , 1993, Glycobiology.

[25]  Y. Yazaki,et al.  Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. , 1993, The Journal of biological chemistry.

[26]  M. Olson,et al.  Platelet-activating factor: receptors and signal transduction. , 1993, The Biochemical journal.

[27]  A. Terano,et al.  Two different promoters direct expression of two distinct forms of mRNAs of human platelet‐activating factor receptor , 1993, FEBS letters.

[28]  Y. Kurachi,et al.  Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. , 1992, Biochemical and biophysical research communications.

[29]  Takao Shimizu,et al.  Endotoxin transduces Ca2+ signaling via platelet‐activating factor receptor , 1992, FEBS letters.

[30]  D. Kunz,et al.  The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. , 1992, The Journal of biological chemistry.

[31]  P. Chomczyński,et al.  One-hour downward alkaline capillary transfer for blotting of DNA and RNA. , 1992, Analytical biochemistry.

[32]  M. Kawamura,et al.  Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. , 1992, The Journal of pharmacology and experimental therapeutics.

[33]  C. Page Mechanisms of hyperresponsiveness: platelet-activating factor. , 1992, The American review of respiratory disease.

[34]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[35]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[36]  K. Isobe,et al.  Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. , 1991, The EMBO journal.

[37]  H. Bito,et al.  Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. , 1991, The Journal of biological chemistry.

[38]  E. Prossnitz,et al.  Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. , 1991, Biochemical and biophysical research communications.

[39]  Takao Shimizu,et al.  Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.

[40]  L. Dubertret,et al.  Production of paf-acether by human epidermal cells. , 1990, The Journal of investigative dermatology.

[41]  G. Zimmerman,et al.  Platelet-activating Factor , 1991 .

[42]  B. Wiggs,et al.  Inhibition of antigen-induced airway hyperresponsiveness, but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor. , 1990, Journal of immunology.

[43]  J. Bates,et al.  The low-frequency dependence of respiratory system resistance and elastance in normal dogs. , 1989, Respiration physiology.

[44]  J. Sugatani,et al.  Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. , 1988, The Journal of clinical investigation.

[45]  R. Halaban,et al.  Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes , 1988, The Journal of cell biology.

[46]  L. Dubertret,et al.  Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. , 1988, Journal of immunology.

[47]  J. Drazen,et al.  Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.

[48]  N. Flavahan,et al.  The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.

[49]  P. Braquet,et al.  The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. , 1988, European journal of pharmacology.

[50]  N. Voelkel,et al.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. , 1987, The Journal of clinical investigation.

[51]  J. Casals-stenzel,et al.  Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. , 1987, European journal of pharmacology.

[52]  F. Cuss,et al.  EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MAN , 1986, The Lancet.

[53]  K. Chung,et al.  Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. , 1986, The Journal of pharmacology and experimental therapeutics.

[54]  Margaret S. Wu,et al.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. , 1985, Biochemical and biophysical research communications.

[55]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[56]  R. Lefkowitz,et al.  Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .

[57]  C. O'neill,et al.  Actions of platelet activating factor (PAF) on gametes and embryos: clinical aspects. , 1992, Reproduction, fertility, and development.

[58]  C. O'neill Embryo-derived platelet activating factor. , 1992 .

[59]  M. Bradl,et al.  Melanosis and associated tumors in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Bradl,et al.  Malignant melanoma in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Behrens,et al.  Control of human T cell proliferation by platelet-activating factor. , 1990, International journal of immunopharmacology.

[62]  C. O'neill,et al.  Embryo-derived platelet-activating factor. , 1989, Journal of reproduction and fertility. Supplement.

[63]  D. Hanahan Platelet activating factor: a biologically active phosphoglyceride. , 1986, Annual review of biochemistry.

[64]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[65]  R. Bowen,et al.  Asthmatic children. , 1948, The Journal-lancet.